Skip to content
stockmarketcap
Discover
Top gainersTop losersMost activeMarket sectorsHeatmapTreasury rates
Earnings calendarIPO calendarEx-dividend calendarEconomic calendar
Congress tradesInsider tradesAnalyst upgrades & downgrades
Collections
ScreenerCompareBacktester
ValuationFundamentals
WatchlistPortfolioPricing
Sign in
Markets
StocksGainersLosersMost activeMarket sectorsHeatmapEarnings calendarCongress tradesInsider tradesAnalyst upgrades/downgradesIPO calendarEx-dividend calendar
Tools
ScreenerCompare stocksReturns backtesterPortfolio trackerWatchlistEmbeddable widget
Metrics
ValuationFundamentals
Popular lists
Best dividend stocksBest value stocksLargest companiesLowest P/E stocks
Collections
All lists & collectionsUS stocksJapanese stocksChinese stocksHong Kong stocksSouth Korean stocksTaiwanese stocksCanadian stocksUK stocksEuropean stocksMagnificent 7AI stocksSemiconductor stocks
Compare
Compare stocksFinviz alternativeKoyfin alternativeTradingView alternativeStockAnalysis alternative
Learn
Investing glossaryHelp & guide
StockMarketCapDocsTokenTermsPrivacyData for information only, not investment advice.
◆

ABT vs GILD

Abbott Laboratories and Gilead Sciences, Inc. compared side by side. Customize this comparison

Performance (normalized)

-31%+9%+49%+88%+128%stockmarketcap.io

Key metrics

MetricABT logoABTGILD logoGILD
Price$95.39$131.27
Market cap$166.15B$162.98B
P/E ratio (TTM)25.19x17.03x
P/S ratio (TTM)3.50x5.28x
Dividend yield2.69%2.55%
Beta0.620.33
1-year return-28.86%+17.72%

Want return correlation and up to five stocks side by side? The advanced compare tool is part of Plus.